High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy.
about
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db miceA potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseasesCannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.Anti-apoptotic effect of hyperglycemia can allow survival of potentially autoreactive T cellsDefining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge.Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.Transcription factors in the pathogenesis of diabetic nephropathy.AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells.Protective effect of statin therapy on connective tissue growth factor induction by diabetes in vivo and high glucose in vitro.Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsExpression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human CancersRole of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells.Aldose Reductase Mediates NLRP3 Inflammasome-Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice.Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose‑treated HK‑2 cells.
P2860
Q27323293-478BCA14-B4F6-4E5F-B666-176FCFD1D7C6Q28382891-2F2D2F54-1011-403D-84B4-36CD4765BD82Q33750632-DFE7E97F-150D-4EE5-B7B5-EF01B64FB9A7Q35092646-FF22023C-EA0F-4CAD-B82F-1128756F7BE0Q37003822-75E3C2A8-527E-458E-9019-824D06C7587EQ37072778-6A457C5C-DB76-4CC2-B31B-B003FC2F91F9Q37461601-86E4B43C-9142-48BD-B1F2-75D35ED9923CQ37601128-CE970C03-BDFC-4CE7-A2AC-1CD183A780B5Q38782030-3A081D43-D5CD-489F-929F-170724FB7FECQ39066860-F1A3B0F6-022A-45CC-AB7B-3CA6A72385CAQ39129556-69AF1C91-2A13-4868-B6F8-2C30CD0D6102Q41815150-26322EA3-B903-45DA-ADF2-223748164968Q43263523-F35BCF7E-4815-4779-99BC-09EEBB0F1595Q46302639-837D3E1F-50D3-475A-B2BC-88A4AF035C2DQ47321983-E22C7F01-344F-4975-B550-19EB3F67DF43
P2860
High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@en
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@nl
type
label
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@en
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@nl
prefLabel
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@en
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@nl
P2093
P1476
High glucose induction of DNA- ...... nts with diabetic nephropathy.
@en
P2093
Andrea Hodgkinson
Andrew G Demaine
Beverley A Millward
Bingmei Yang
Peter J Oates
P304
P356
10.1016/J.BBADIS.2008.01.009
P577
2008-02-15T00:00:00Z